Why the study?
The predictive power of SYNTAX versus Gensini scores for heart team decisions regarding surgical or percutaneous revascularization in patients with three-vessel CAD required evaluation.
Does the SYNTAX score better predict heart team decisions for revascularization compared to the Gensini score in patients with three-vessel coronary artery disease?
Does the SYNTAX score better predict heart team decisions for revascularization compared to the Gensini score in patients with three-vessel coronary artery disease?
The SYNTAX score is a better predictor of heart team decisions regarding surgery versus percutaneous revascularization than the Gensini score in patients with three-vessel CAD.
May guide intervention decisions in multi-vessel CAD; leaves open comparative predictive value of SYNTAX and Gensini scores.
INTRODUCTION: Many scoring systems have been developed to determine the extent of coronary artery disease (CAD) in patients with multi-vessel disease. The most widely used of these are Synergy between percutaneous coronary intervention with Taxus and cardiac surgery (SYNTAX) and Gensini scoring. Gensini scoring system can successfully show coronary plaque burden. In our study, we aimed to test the predictive power of SYNTAX and Gensini scores for surgical or percutaneous intervention decisions made by the cardiac team in patients with three-vessel disease. METHODS: A total of 476 patients without ST-elevation myocardial infarction with the three-vessel disease were included in the study. SYNTAX and Gensini scores of the patients were calculated from their coronary angiographies. Receiver operating characteristic curve (ROC-curve) analysis was performed using both scores. RESULTS: Both the SYNTAX score and Gensini score were able to predict heart team decisions (AUC: 0.759, 0.680; p<0.001). Diabetes and smoking were more common in patients who were decided to have surgery (p<0.001). CONCLUSION: In the light of our study results, the decisions to be made with the SYNTAX score will be closer to the decisions of the heart team than the Gensini score.
No takes yet. Share an insight, caveat, or question.
Boyraz et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: